Adverse drug reactions among children with tuberculosis in China: a multicentre study, 2017–2022

20260 citationsJournal Articlegold Open Access

Authors

Yiqing Zhou · Hangzhou Medical College

Yu Kan · Zhejiang Chinese Medical University

Ping Liu · Shanghai Public Health Clinical Center

Hongmei Xu · Children's Hospital of Chongqing Medical University

Juan Ma · Qingdao University

Hongxia Li · Wenzhou Medical University

Xin Yu ·

Abstract

ADRs are prevalent in Chinese paediatric TB patients, predominantly haematological or gastrointestinal, transient during the intensive phase. Severe disease and HRZ(E) + second-line regimens confer elevated risk, necessitating targeted surveillance and optimized paediatric therapies balancing efficacy and safety.

Topics & Keywords

Pharmacovigilance and Adverse Drug Reactions Pharmaceutical studies and practices Tuberculosis Research and Epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Medicine

Volume 58, Issue 1, pp. 2645734-2645734

DOI: 10.1080/07853890.2026.2645734

Field-Weighted Citation Impact: 0.00